CorMedix Inc. (NASDAQ:CRMD) Q4 2025 Earnings Call Transcript March 5, 2026 CorMedix Inc. misses on earnings expectations. Reported EPS is $0.1493 EPS, expectations were $0.86. Operator: Good morning, ...

Good morning, and welcome to the CorMedix Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. Leading the call tod ...

Joseph Todisco EVP and Chief Operating Officer — Elizabeth Masson-Hurlburt EVP and Chief Financial Officer — Susan Blum ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Philip McKibbin does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Right now, many companies are worried about how to get more employees to use AI. After all, the promise of AI reducing the burden of some work—drafting routine documents, summarizing information, and ...

When university students get to create real value for others, their motivation, self-confidence, and academic performance increase. This is shown by a new study published in The International Journal ...

Manufactured homes have come a long way in design, durability, and buyer perception. Today, they are a legitimate and attractive housing option for first-time buyers, retirees, and investors alike.

The questionable return-on-investment for AI just took another hit, with a recent study pointing to the technology creating a lot of correction work for employees that use it. Modern AI technology has ...

Now, a Dartmouth study identifies a neural receptor that promotes the therapeutic benefits of psilocybin but is non-hallucinogenic. The findings, reported in Molecular Psychiatry, may provide a new ...